HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy.

Abstract
Endovenously administered oncolytic viruses extravasate and penetrate poorly into tumors. iRGD is a cyclic peptide that enhances tumor penetration when conjugated or coadministered with different types of molecules such as drugs, nanoparticles or phages. iRGD-mediated tumor penetration occurs in three steps: binding to αv-integrins on tumor vasculature or tumor cells, exposure by proteolysis of a C-terminal motif that binds to neuropilin-1 (NRP-1) and cell internalization. We have genetically inserted the iRGD peptide in the fiber C terminus of ICOVIR15K, an oncolytic tumor-retargeted adenovirus to increase its tumor penetration. In vitro, NRP-1 interaction improved binding and internalization of the virus in different cancer cells overexpressing integrins and NRP-1. However, such NRP-1-mediated internalization did not affect transduction or cytotoxicity. In vivo, iRGD did not change the normal organ transduction pattern, with liver and spleen as main targeted organs. In tumors, however, iRGD enhanced transduction and early adenovirus dissemination through the tumor mass leading to an improved antitumor efficacy.
AuthorsC Puig-Saus, L A Rojas, E Laborda, A Figueras, R Alba, C Fillat, R Alemany
JournalGene therapy (Gene Ther) Vol. 21 Issue 8 Pg. 767-74 (Aug 2014) ISSN: 1476-5462 [Electronic] England
PMID24942629 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • N-end cysteine peptide tumor-homing peptide
  • Oligopeptides
  • Neuropilin-1
Topics
  • Amino Acid Motifs
  • Animals
  • Cell Line, Tumor
  • Drug Delivery Systems (methods)
  • Female
  • Genetic Therapy (methods)
  • HEK293 Cells
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • MCF-7 Cells
  • Mice, Inbred BALB C
  • Neuropilin-1 (metabolism)
  • Oligopeptides (therapeutic use)
  • Oncolytic Virotherapy (methods)
  • Virus Internalization
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: